Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

West Africa Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The West Africa generic drug market is currently witnessing moderate growth. Generic drugs are bioequivalent of branded drugs in terms of their strength, dosage, safety, quality, performance and efficiency. These drugs are more affordable than their counterparts as the manufacturers do not need to invest in marketing or testing the efficiency and strength of these medicines. Since they are proven to be safe and effective as branded drugs, the demand for generic drugs is escalating in the West African region.

The increasing prevalence of infectious diseases, such as malaria, tuberculosis (TB), and acquired immune deficiency syndrome (AIDS), along with the outbreak of meningitis, polio, pandemic influenza, cholera, measles, hepatitis, tetanus and yellow fever, are positively influencing the demand for generic drugs in the West African region. Moreover, governing authorities of various countries are focusing on investing in the healthcare sectors to reduce the number of deaths caused by the lack of essential drugs. This, in turn, is driving the market of generic drugs in the region. However, the sudden outbreak of the coronavirus disease (COVID-19) and the implementation of lockdown restrictions have hampered the production of generic drugs in the region. The market will experience growth once lockdown restrictions are reduced. Looking forward, the market is expected to continue its moderate during the forecast period (2021-2026).

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the West Africa generic drug market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, segment, therapy area, drug delivery and distribution channel.

Breakup by Segment:

  • Unbranded Generics
  • Branded Generics
     

Breakup by Therapy Area:

  • Central Nervous System
  • Cardiovascular
  • Dermatology
  • Genitourinary/Hormonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others
     

Breakup by Drug Delivery:

  • Oral
  • Injectables
  • Dermal/Topical
  • Inhalers
     

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
     

Breakup by Country:

  • Nigeria
  • Ghana
  • Cote d’Ivoire
  • Senegal
  • Mali
  • Others
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key Questions Answered in This Report:

  • How has the West Africa generic drug market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the West Africa generic drug market?
  • What are the key regional markets?
  • What is the breakup of the market based on the segment?
  • What is the breakup of the market based on the therapy area?
  • What is the breakup of the market based on the drug delivery?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the market?
  • What is the structure of the West Africa generic drug market and who are the key players?
  • What is the degree of competition in the market?

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   West Africa Generic Drug Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Segment
    6.1    Unbranded Generics
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Branded Generics
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Therapy Area
    7.1   Central Nervous System
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cardiovascular
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Dermatology
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Genitourinary/Hormonal
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Respiratory
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Rheumatology
        7.6.1 Market Trends
        7.6.2 Market Forecast
    7.7    Diabetes
        7.7.1 Market Trends
        7.7.2 Market Forecast
    7.8    Oncology
        7.8.1 Market Trends
        7.8.2 Market Forecast
    7.9    Others
        7.9.1 Market Trends
        7.9.2 Market Forecast
8    Market Breakup by Drug Delivery
    8.1   Oral
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Injectables
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Dermal/Topical
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Inhalers
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Retail Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Hospital Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
10    Market Breakup by Country
    10.1    Nigeria
        10.1.1 Market Trends
        10.1.2 Market Breakup by Segment
        10.1.3 Market Breakup by Therapy Area
        10.1.4 Market Breakup by Drug Delivery
        10.1.5 Market Breakup by Distribution Channel
        10.1.6 Market Forecast
    10.2    Ghana
        10.2.1 Market Trends
        10.2.2 Market Breakup by Segment
        10.2.3 Market Breakup by Therapy Area
        10.2.4 Market Breakup by Drug Delivery
        10.2.5 Market Breakup by Distribution Channel
        10.2.6 Market Forecast
    10.3    Cote d’Ivoire
        10.3.1 Market Trends
        10.3.2 Market Breakup by Segment
        10.3.3 Market Breakup by Therapy Area
        10.3.4 Market Breakup by Drug Delivery
        10.3.5 Market Breakup by Distribution Channel
        10.3.6 Market Forecast
    10.4    Senegal
        10.4.1 Market Trends
        10.4.2 Market Breakup by Segment
        10.4.3 Market Breakup by Therapy Area
        10.4.4 Market Breakup by Drug Delivery
        10.4.5 Market Breakup by Distribution Channel
        10.4.6 Market Forecast
    10.5    Mali
        10.5.1 Market Trends
        10.5.2 Market Breakup by Segment
        10.5.3 Market Breakup by Therapy Area
        10.5.4 Market Breakup by Drug Delivery
        10.5.5 Market Breakup by Distribution Channel
        10.5.6 Market Forecast
10.6    Others
        10.6.1 Market Trends
        10.6.2 Market Breakup by Segment
        10.6.3 Market Breakup by Therapy Area
        10.6.4 Market Breakup by Drug Delivery
        10.6.5 Market Breakup by Distribution Channel
        10.6.6 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Policy and Regulatory Landscape
16    Competitive Landscape

    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players

List of Figures

Figure 1: West Africa: Generic Drug Market: Major Drivers and Challenges
Figure 2: West Africa: Generic Drug Market: Sales Value (in Million US$), 2015-2020
Figure 3: West Africa: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: West Africa: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 5: West Africa: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 6: West Africa: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 7: West Africa: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 8: West Africa: Generic Drug Market: Breakup by Country (in %), 2020
Figure 10: West Africa: Generic Drug (Unbranded Generics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: West Africa: Generic Drug (Unbranded Generics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: West Africa: Generic Drug (Branded Generics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: West Africa: Generic Drug (Branded Generics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: West Africa: Generic Drug (Central Nervous System) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: West Africa: Generic Drug (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: West Africa: Generic Drug (Cardiovascular) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: West Africa: Generic Drug (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: West Africa: Generic Drug (Dermatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: West Africa: Generic Drug (Dermatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: West Africa: Generic Drug (Genitourinary/Hormonal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: West Africa: Generic Drug (Genitourinary/Hormonal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: West Africa: Generic Drug (Respiratory) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: West Africa: Generic Drug (Respiratory) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: West Africa: Generic Drug (Rheumatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: West Africa: Generic Drug (Rheumatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: West Africa: Generic Drug (Diabetes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: West Africa: Generic Drug (Diabetes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: West Africa: Generic Drug (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: West Africa: Generic Drug (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: West Africa: Generic Drug (Other Therapy Areas) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: West Africa: Generic Drug (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: West Africa: Generic Drug (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: West Africa: Generic Drug (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: West Africa: Generic Drug (Injectables) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: West Africa: Generic Drug (Injectables) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: West Africa: Generic Drug (Dermal/Topical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: West Africa: Generic Drug (Dermal/Topical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: West Africa: Generic Drug (Inhalers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: West Africa: Generic Drug (Inhalers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: West Africa: Generic Drug (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: West Africa: Generic Drug (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: West Africa: Generic Drug (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: West Africa: Generic Drug (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Nigeria: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Nigeria: Generic Drug Market: Breakup by Product (in %), 2020
Figure 46: Nigeria: Generic Drug Market: Breakup by Type (in %), 2020
Figure 47: Nigeria: Generic Drug Market: Breakup by Packaging Type (in %), 2020
Figure 48: Nigeria: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 49: Nigeria: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Ghana: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Ghana: Generic Drug Market: Breakup by Product (in %), 2020
Figure 52: Ghana: Generic Drug Market: Breakup by Type (in %), 2020
Figure 53: Ghana: Generic Drug Market: Breakup by Packaging Type (in %), 2020
Figure 54: Ghana: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 55: Ghana: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Cote d’Ivoire: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Cote d’Ivoire: Generic Drug Market: Breakup by Product (in %), 2020
Figure 58: Cote d’Ivoire: Generic Drug Market: Breakup by Type (in %), 2020
Figure 59: Cote d’Ivoire: Generic Drug Market: Breakup by Packaging Type (in %), 2020
Figure 60: Cote d’Ivoire: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 61: Cote d’Ivoire: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Senegal: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Senegal: Generic Drug Market: Breakup by Product (in %), 2020
Figure 64: Senegal: Generic Drug Market: Breakup by Type (in %), 2020
Figure 65: Senegal: Generic Drug Market: Breakup by Packaging Type (in %), 2020
Figure 66: Senegal: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 67: Senegal: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Mali: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Mali: Generic Drug Market: Breakup by Product (in %), 2020
Figure 70: Mali: Generic Drug Market: Breakup by Type (in %), 2020
Figure 71: Mali: Generic Drug Market: Breakup by Packaging Type (in %), 2020
Figure 72: Mali: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 73: Mali: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Others: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Others: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: West Africa: Generic Drug Industry: SWOT Analysis
Figure 77: West Africa: Generic Drug Industry: Value Chain Analysis
Figure 78: West Africa: Generic Drug Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: West Africa: Generic Drug Market: Key Industry Highlights, 2020 and 2026
Table 2: West Africa: Generic Drug Market Forecast: Breakup by Segment (in Million US$), 2021-2026
Table 3: West Africa: Generic Drug Market Forecast: Breakup by Therapy Area (in Million US$), 2021-2026
Table 4: West Africa: Generic Drug Market Forecast: Breakup by Drug Delivery (in Million US$), 2021-2026
Table 5: West Africa: Generic Drug Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: West Africa: Generic Drug Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 7: West Africa: Generic Drug Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links